Schrumpf E - Search Results

1

Liver transplantation for endstage hepatitis C cirrhosis in a patient with primary hypogammaglobulinaemia.

Bjøro K, Schrumpf E, Bergan A, Haaland T, Skaug K, Frøland SS. Bjøro K, et al. Among authors: schrumpf e. Scand J Infect Dis. 1998;30(5):520-2. doi: 10.1080/00365549850161575. Scand J Infect Dis. 1998. PMID: 10066058

2

Liver TX for hepatitis C cirrhosis in a low prevalence population: risk factors and status at evaluation.

Melum E, Schrumpf E, Bjøro K. Melum E, et al. Among authors: schrumpf e. Scand J Gastroenterol. 2006 May;41(5):592-6. doi: 10.1080/00365520500347113. Scand J Gastroenterol. 2006. PMID: 16638703

3

Liver transplantation in the Nordic countries, 1982-1998: changes of indications and improving results.

Bjøro K, Friman S, Höckerstedt K, Kirkegaard P, Keiding S, Schrumpf E, Olausson M, Oksanen A, Isoniemi H, Hjortrup A, Bergan A, Ericzon BG. Bjøro K, et al. Among authors: schrumpf e. Scand J Gastroenterol. 1999 Jul;34(7):714-22. doi: 10.1080/003655299750025930. Scand J Gastroenterol. 1999. PMID: 10466884

4

[Hepatitis C].

Bjøro K, Schrumpf E. Bjøro K, et al. Among authors: schrumpf e. Tidsskr Nor Laegeforen. 1992 Nov 30;112(29):3654-5. Tidsskr Nor Laegeforen. 1992. PMID: 1471122 Norwegian. No abstract available.

5

Liver transplantation for primary sclerosing cholangitis.

Bjøro K, Schrumpf E. Bjøro K, et al. Among authors: schrumpf e. J Hepatol. 2004 Apr;40(4):570-7. doi: 10.1016/j.jhep.2004.01.021. J Hepatol. 2004. PMID: 15030971 Review. No abstract available.

6

Liver transplantation in primary sclerosing cholangitis.

Bjøro K, Brandsaeter B, Foss A, Schrumpf E. Bjøro K, et al. Among authors: schrumpf e. Semin Liver Dis. 2006 Feb;26(1):69-79. doi: 10.1055/s-2006-933565. Semin Liver Dis. 2006. PMID: 16496235 Review.

7

Liver transplantation in the Nordic countries - An intention to treat and post-transplant analysis from The Nordic Liver Transplant Registry 1982-2013.

Fosby B, Melum E, Bjøro K, Bennet W, Rasmussen A, Andersen IM, Castedal M, Olausson M, Wibeck C, Gotlieb M, Gjertsen H, Toivonen L, Foss S, Makisalo H, Nordin A, Sanengen T, Bergquist A, Larsson ME, Soderdahl G, Nowak G, Boberg KM, Isoniemi H, Keiding S, Foss A, Line PD, Friman S, Schrumpf E, Ericzon BG, Höckerstedt K, Karlsen TH. Fosby B, et al. Among authors: schrumpf e. Scand J Gastroenterol. 2015 Jun;50(6):797-808. doi: 10.3109/00365521.2015.1036359. Scand J Gastroenterol. 2015. PMID: 25959101 Free PMC article.

8

Interferon-alpha 2b, with or without prior hepatic artery embolization: clinical response and survival in mid-gut carcinoid patients. The Norwegian carcinoid study.

Jacobsen MB, Hanssen LE, Kolmannskog F, Schrumpf E, Vatn MH, Bergan A. Jacobsen MB, et al. Among authors: schrumpf e. Scand J Gastroenterol. 1995 Aug;30(8):789-96. doi: 10.3109/00365529509096329. Scand J Gastroenterol. 1995. PMID: 7481548 Clinical Trial.

9

Monstrous ascites in hereditary haemorrhagic telangiectasia.

Bjøro K, Schrumpf E, Elgjo K, Kolmanskog F. Bjøro K, et al. Among authors: schrumpf e. Scand J Gastroenterol. 1995 Jan;30(1):92-4. doi: 10.3109/00365529509093242. Scand J Gastroenterol. 1995. PMID: 7701258

10

Hepatobiliary disease in ulcerative colitis. An analysis of 18 patients with hepatobiliary lesions classified as small-duct primary sclerosing cholangitis.

Boberg KM, Schrumpf E, Fausa O, Elgjo K, Kolmannskog F, Haaland T, Holter E. Boberg KM, et al. Among authors: schrumpf e. Scand J Gastroenterol. 1994 Aug;29(8):744-52. doi: 10.3109/00365529409092504. Scand J Gastroenterol. 1994. PMID: 7973436

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

257 results

Search Page